Top Markets
Coin of the day
Cabio Biotech (Wuhan) Co., Ltd. Cabio Biotech (Wuhan) Co., Ltd.

Cabio Biotech (Wuhan) Co., Ltd.

688089
Rank in Stocks #18131
Cabio Biotech (Wuhan) Co., Ltd. engages in the research, development,... Cabio Biotech (Wuhan) Co., Ltd. engages in the research, development, production and sale of polyunsaturated fatty acids and nutrition products. Its products include arachidonic acids (ARA), docosahexaenoic acids (DHA), natural beta-carotene products, infant formula food, functional healthcare food and dietary supplements. The company was founded on September 22, 2004 and is headquartered in Wuhan, China.
Share Price
$1.23
Market Cap
$207.07M
Change (1 day)
-1.16%
Change (1 year)
-66.85%
Country
CN
Trade Cabio Biotech (Wuhan) Co., Ltd. (688089)

Category

P/B ratio for Cabio Biotech (Wuhan) Co., Ltd. (688089)
P/B ratio as of 2026 TTM: 0
According to Cabio Biotech (Wuhan) Co., Ltd. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Cabio Biotech (Wuhan) Co., Ltd. from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
6.828 -
US
7.5116 -
NL
8.2199 -
US
3.9942 -
AU
- -
CH